Postpartum Anemia
Conditions
Brief summary
Investigator is doing this study to understand the best way to give iron supplements to mothers after delivery who already have a normal blood level (hemoglobin). Some guidelines recommend one approach, while others recommend a different approach. In this study, investigator will compare these two methods to see which one is more helpful and suitable for mothers. Participants participation will help us improve care for women after childbirth in the future. Taking part is participants choice, and all participants information will be kept private.
Detailed description
Postpartum women may be at risk of developing iron deficiency and postpartum anemia due to blood loss during childbirth. Iron supplementation after delivery is commonly used to prevent anemia; however, the benefit of routine iron supplementation in postpartum women who already have normal hemoglobin levels remains an area of discussion. This randomized controlled trial aims to compare routine iron supplementation with no iron supplementation in postpartum women with normal hemoglobin levels. Eligible postpartum women with normal hemoglobin levels will be randomly allocated into two groups. The intervention group will receive Polymalt F (iron polymaltose complex with folic acid), one tablet daily for 6 weeks postpartum. The control group will not receive routine iron supplementation during the study period and will receive standard postpartum care. Participants will be followed up at 6 weeks postpartum. Maternal outcomes will be assessed, including hemoglobin level, development of postpartum anemia, fatigue level,compliance with supplementation, and any reported side effects among participants receiving iron. The primary outcome of this study is to determine whether routine iron supplementation prevents postpartum anemia in women with normal hemoglobin levels. The findings may help provide evidence regarding the need for routine iron supplementation after childbirth and improve postpartum care practices.
Interventions
DRUGIron Polymaltose Complex with folic acid
Participants in the intervention group will receive drug Polymalt F (iron polymaltose complex with folic acid), one tablet orally once daily for 6 weeks after delivery. The purpose of this intervention is to evaluate whether routine iron supplementation helps prevent postpartum anemia in women with normal hemoglobin levels.
Sponsors
Sana Nadeem Qasir
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Intervention model description
Participants will be randomly assigned to one of two parallel groups. The intervention group will receive Polymalt F (iron polymaltose complex with folic acid), one tablet daily for 6 weeks postpartum, while the control group will receive standard postpartum care without routine iron supplementation. Outcomes will be compared between the two groups at 6 weeks postpartum.
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No
Inclusion criteria
* Women aged 18-40 years * Single Term Vaginal delivery * Hemoglobin ≥10.5 g/dL at 24hour of delivery * Willing for follow-up
Exclusion criteria
* Postpartum hemorrhage * Hemoglobin \<10.5 g/dL * Blood transfusion received * Known hematological disease * Chronic liver or kidney disease * Cesarian section
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in postpartum hemoglobin levels /development of postpartum anemia | 6week | The primary outcome is to assess the effectiveness of routine iron supplementation in preventing postpartum anemia among women with normal hemoglobin levels. Hemoglobin levels will be measured at 6 weeks postpartum and compared between the iron supplementation group and the no iron supplementation group. |
Countries
Pakistan
Contacts
CONTACTSana Nadeem Qasir, MBBs,trainee FCPS
CONTACTProf.Dr.SARAH Jamil khan, consultant
PRINCIPAL_INVESTIGATORProf.Dr Sarah Jamil Khan, Consultant gynaecologist
Outcome results
None listed